Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human FUBP1 Protein, N-His

Catalog #:   YHJ37101 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: Q96AE4
Protein length: Ala2-Asn228
Overview

Catalog No.

YHJ37101

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Ala2-Asn228

Predicted molecular weight

25.76 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

Q96AE4

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

FUSE-binding protein 1, Far upstream element-binding protein 1, DNA helicase V, FBP, FUBP1, hDH V

Data Image
  • SDS-PAGE
    SDS PAGE for recombinant Human FUBP1 protein
References

Evaluation of 3,606 renal cell tumors for TFE3 rearrangements and TFEB alterations via fluorescence in situ hybridization, next generation sequencing, and GPNMB immunohistochemistry., PMID:40381702

A dual effect of FUBP1 on SPA lncRNA maturation., PMID:40147944

TERTp Mutation and its Prognostic Value in Glioma Patients Under the 2021 WHO Classification: A Real-World Study., PMID:39804195

Facilitation of diabetic wound healing by far upstream element binding protein 1 through augmentation of dermal fibroblast activity., PMID:39412701

USP7 depletion potentiates HIF2α degradation and inhibits clear cell renal cell carcinoma progression., PMID:39406703

In pancreatic cancer patients, chemotherapy reshapes the gene expression profile and antigen receptor repertoire of T lymphocytes and enhances their effector response to tumor-associated antigens., PMID:39176093

PRMT5-mediated FUBP1 methylation accelerates prostate cancer progression., PMID:39146021

Pathogenic gene connections in type 2 diabetes and non-alcoholic fatty liver disease: a bioinformatics analysis and mouse model investigations experiments., PMID:39107295

FUBP1 in human cancer: Characteristics, functions, and potential applications., PMID:39067088

Genomic Alterations in Molecularly Defined Oligodendrogliomas., PMID:39007559

Analysis of the Anticancer Mechanism of OR3 Pigment from Streptomyces coelicolor JUACT03 Against the Human Hepatoma Cell Line Using a Proteomic Approach., PMID:38578403

tiRNA-Val-CAC-2 interacts with FUBP1 to promote pancreatic cancer metastasis by activating c‑MYC transcription., PMID:38443680

USP29 activation mediated by FUBP1 promotes AURKB stability and oncogenic functions in gastric cancer., PMID:38233848

Identifying BMI-associated genes via a genome-wide multi-omics integrative approach using summary data., PMID:38215789

The Link of mRNA and rRNA Transcription by PUF60/FIR through TFIIH/P62 as a Novel Therapeutic Target for Cancer., PMID:38139171

Integration of risk variants from GWAS with SARS-CoV-2 RNA interactome prioritizes FUBP1 and RAB2A as risk genes for COVID-19., PMID:37932299

Circulating autoantibodies to alpha-enolase (ENO1) and far upstream element-binding protein 1 (FUBP1) are negative prognostic factors for pancreatic cancer patient survival., PMID:37910256

The expression and clinical value of LRP11, FUBP1 and TET1 in cervical cancer., PMID:37715422

Icariin activates far upstream element binding protein 1 to regulate hypoxia-inducible factor-1α and hypoxia-inducible factor-2α signaling and benefits chondrocytes., PMID:37637163

Genomic alterations of oligodendrogliomas at distant recurrence., PMID:37533228

FUBP1 is a general splicing factor facilitating 3' splice site recognition and splicing of long introns., PMID:37506698

Structural insights into a regulatory mechanism of FIR RRM1-FUSE interaction., PMID:37253421

The NR_109/FUBP1/c-Myc axis regulates TAM polarization and remodels the tumor microenvironment to promote cancer development., PMID:37217247

Genomic profiles of IDH-mutant gliomas: MYCN-amplified IDH-mutant astrocytoma had the worst prognosis., PMID:37185778

Far upstream element-binding protein 1 confers lobaplatin resistance by transcriptionally activating PTGES and facilitating the arachidonic acid metabolic pathway in osteosarcoma., PMID:37180822

circPTPN14 promotes renal fibrosis through its interaction with FUBP1 to enhance MYC transcription., PMID:37014433

circMMD reduction following tumor treating fields inhibits glioblastoma progression through FUBP1/FIR/DVL1 and miR-15b-5p/FZD6 signaling., PMID:36932454

LncRNA NIPA1-SO confers atherosclerotic protection by suppressing the transmembrane protein NIPA1., PMID:36736696

Psi promotes Drosophila wing growth via direct transcriptional activation of cell cycle targets and repression of growth inhibitors., PMID:36692218

Locus-Specific Isolation of the Nanog Chromatin Identifies Regulators Relevant to Pluripotency of Mouse Embryonic Stem Cells and Reprogramming of Somatic Cells., PMID:36499566

Targeted DNA sequencing to identify genetic aberrations in glioblastoma that underlie venous thromboembolism; a cohort study., PMID:36435047

A mass spectrometry-based approach for the identification of Kpnβ1 binding partners in cancer cells., PMID:36418423

A circular RNA, circPTPN14, increases MYC transcription by interacting with FUBP1 and exacerbates renal fibrosis., PMID:36394649

Discovery of Anthranilic Acid Derivatives as Difluoromethylornithine Adjunct Agents That Inhibit Far Upstream Element Binding Protein 1 (FUBP1) Function., PMID:36382923

The cuproptosis-related signature associated with the tumor environment and prognosis of patients with glioma., PMID:36110851

Differential expression profiling of onco and tumor-suppressor genes from major-signaling pathways in Wilms' tumor., PMID:36107237

FUBP1 promotes the proliferation of lung squamous carcinoma cells and regulates tumor immunity through PD-L1., PMID:36086966

A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk., PMID:36082445

Extracellular 5'-methylthioadenosine inhibits intracellular symmetric dimethylarginine protein methylation of FUSE-binding proteins., PMID:35963436

Cross-ancestry genome-wide meta-analysis of 61,047 cases and 947,237 controls identifies new susceptibility loci contributing to lung cancer., PMID:35915169

Comparative Proteomic Profiling of Cisplatin-resistant Nasopharyngeal Carcinoma Cell Lines: Novel Biomarkers for Improving Chemotherapy of NPC., PMID:35790268

TRAF7 somatic mosaicism in a patient with bilateral optic nerve sheath meningiomas: illustrative case., PMID:35733823

Utility of targeted next-generation sequencing assay to detect 1p/19q co-deletion in formalin-fixed paraffin-embedded glioma specimens., PMID:35561840

Intra-axonal translation of Khsrp mRNA slows axon regeneration by destabilizing localized mRNAs., PMID:35556128

Far upstream element -binding protein 1 (FUBP1) participates in the malignant process and glycolysis of colon cancer cells by combining with c-Myc., PMID:35546072

Pan-Cancer Transcriptome and Immune Infiltration Analyses Reveal the Oncogenic Role of Far Upstream Element-Binding Protein 1 (FUBP1)., PMID:35274005

Effect of RNA Interference Inhibiting the Expression of the FUBP1 Gene on Biological Function of Gastric Cancer Cell Line SGC7901., PMID:34872893

Long non-coding RNA KRT8P41/miR-193a-3p/FUBP1 axis modulates the proliferation and invasion of chordoma cells., PMID:34712553

Long-Term Report of a Comprehensive Molecular and Genomic Analysis in NRG Oncology/RTOG 0424: A Phase II Study of Radiation and Temozolomide in High-Risk Grade II Glioma., PMID:34589661

Identifying a possible new target for diagnosis and treatment of postmenopausal osteoporosis through bioinformatics and clinical sample analysis., PMID:34430595

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human FUBP1 Protein, N-His [YHJ37101]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only